Deep vein thrombosis: Difference between revisions
No edit summary |
m (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu)) |
||
Line 18: | Line 18: | ||
'''For main page on Venous thrombosis, click [[Venous thrombosis|here]] | '''For main page on Venous thrombosis, click [[Venous thrombosis|here]] | ||
'''Editor(s)-In-Chief:''' {{ATI}}, [[C. Michael Gibson, M.S., M.D.]] [mailto: | '''Editor(s)-In-Chief:''' {{ATI}}, [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com]; '''Associate Editor(s)-In-Chief:''' {{CZ}}; [[User:Kashish Goel|Kashish Goel, M.D.]]; '''Assistant Editor(s)-In-Chief:''' [[User:Justine Cadet|Justine Cadet]] | ||
{{SK}} DVT | {{SK}} DVT |
Revision as of 14:55, 1 November 2012
Deep vein thrombosis | |
ICD-10 | I80.2 |
---|---|
ICD-9 | 453.40 |
DiseasesDB | 3498 |
MeSH | D020246 |
Deep Vein Thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Special Scenario |
Trials |
Case Studies |
Deep vein thrombosis On the Web |
For patient information page, click here
For main page on Venous thrombosis, click here
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Kashish Goel, M.D.; Assistant Editor(s)-In-Chief: Justine Cadet
Synonyms and keywords: DVT
Overview
Classification
Pathophysiology
Differentiating Deep vein thrombosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnosis Approach | Pretest probability | History and Symptoms | Physical Examination | D-dimer | Ultrasound | Venography | CT scan venography | MRI | Other Imaging Findings
Specific scenarios
Treatment
- Anticoagulation: Unfractionated Heparin | Low molecular weight heparin | Factor Xa inhibitor | Direct thrombin inhibitor | Warfarin
- Fibrinolysis: Catheter directed thrombolysis | Systemic thrombolysis
Guidelines
ACCP Guidelines
Treatment Guidelines
- Recommendations for initial approach for acute DVT of the leg | Recommendations for initial choice of treatment for acute DVT of the leg | Recommendations for duration of anticoagulant therapy | Recommendations for intensity of anticoagulant effect | Recommendations for treatment of isolated distal DVT | Recommendations for treatment of asymptomatic DVT of the leg | Recommendations for treatment in special situations | Recommendations for post-thrombotic syndrome
Thromboprophylaxis Guidelines
- Recommendations for patients undergoing non-orthopedic surgery : General surgery, GI surgery, Urological surgery and Gynecologic surgery, Bariatric surgery, Vascular surgery, and Plastic and Reconstructive surgery | Recommendations for Cardiac Surgery patients | Recommendations for Thoracic Surgery patients | Recommendations for Patients undergoing Craniotomy | Recommendations for Spinal Surgery Patients | Recommendations for Major Trauma Patients
- Recommendations for patients undergoing Orthopedic surgery : Recommendations for patients undergoing undergoing THA, TKA, HFS | Recommendations for Isolated Lower-Leg Injuries Distal to the Knee | Recommendations for patients undergoing Knee arthroscopy
- Recommendations for prevention of VTE in nonsurgical patients: Recommendations for Hospitalized Acutely Ill patients | Recommendations for Critically Ill patients | Recommendations for Cancer patients in an outpatient setting | Recommendations for Chronically Immobilized outpatients | Recommendations for Long-distance Travel | Recommendations for Asymptomatic Persons with Thrombophilia
AHA Guidelines
Landmarks Trials
Landmark Trials in DVT Treatment | Landmark Trials in DVT Prevention
Case Studies
References
Related Chapters
ar:تجلط الوريد العميق it:Trombosi venosa profonda nl:Diep-veneuze trombose